Reviva Pharmaceuticals Holdings Inc. Warrants (25/12/2025) RVPHW 深 沪
等待开盘 09-23 09:30:00 美东时间
0.0449
+0.000
+0.67%
华盛通- 最 高0.05
- 今 开0.0499
- 成交量 3.08万股
- 最 低 0.0446
- 昨 收 0.0446
- 总市值 41.45万
- 52周最高 0.78
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.0226
- 委 比 -99.90%
- 总股本 923.17万
- 历史最高 3.00
- 量 比 0.47
- 振 幅 12.11%
- 历史最低 0.0226
- 每 手 1
- 风险率 0.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Reviva Pharmaceuticals Announces Public Offering to Raise Funds
Reviva Pharmaceuticals Holdings ( ($RVPH) ) has shared an announcement. On Sept...
09-20 05:44
Top 3 Health Care Stocks That May Explode In September
The most oversold stocks in the health care sector presents an opportunity to b...
09-19 19:01
Why FedEx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Shares of FedEx Corporation (NYSE:FDX) rose sharply in pre-market trading after...
09-19 17:25
Reviva Pharmaceuticals announces proposed public offering
Reviva Pharmaceuticals Holdings (NASDAQ:RVPH) on Thursday said it intends to offer shares of its common stock and warrants to purchase shares of common stock in a public offering. All of the securitie...
09-19 04:18
Benchmark Maintains Speculative Buy on Reviva Pharmaceuticals, Lowers Price Target to $7
Benchmark analyst Bruce D. Jackson maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Speculative Buy and lowers the price target from $14 to $7.
09-15 21:01
Reviva Pharmaceuticals Advances Schizophrenia Treatment
Reviva Pharmaceuticals Holdings, Inc. ( ($RVPH) ) has released its Q2 earnings....
08-19 12:11
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $3 Price Target
D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $3 price target.
08-18 19:27
Reviva Pharmaceuticals Holdings shares are trading higher after the company reportedbetter-than-expected Q2 EPS results.
Reviva Pharmaceuticals Holdings shares are trading higher after the company rep...
08-15 22:54
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Adial Pharmaceuticals (NASDAQ:ADIL) stock moved upwards by 19.6% to $0...
06-26 05:06
Reviva Pharmaceuticals announces public offering; shares down nearly 15%
Reviva Pharmaceuticals (NASDAQ:RVPH) plans to offer common stock or equivalents and warrants in a public offering. All securities in the offering will be sold by the company. Proceeds will support R&D...
06-26 04:28
